ACD Pharma
ACM Pharma is a French B2B microbiological testing laboratory (NF EN ISO/CEI 17025-accredited, GMP-compliant) serving pharmaceutical, cosmetic, biopharmaceutical, medical device, biocides, and nutraceutical manufacturers with contamination control, method validation, and disinfectant efficacy testing.
- Company typePrivate
- Founded2011
- HeadquartersLeknes, Norway
- Headcount51–100
- GTM typeB2B
- OfferingServices
What ACD Pharma does
ACM Pharma (legal entity: SARL ACM Pharma, also trading as Fonderephar) is a privately held B2B microbiological testing laboratory headquartered in Bellegarde, France, with a second site in Toulouse (Canal Biotech 2). Founded as a specialist in contamination control for health industries, the company delivers GMP-compliant microbiological and physico-chemical testing, method development and validation, cleaning validation, environmental monitoring, and disinfectant efficacy testing to manufacturers across six regulated verticals: pharmaceutical, biopharmaceutical, cosmetic, medical device, biocides, and nutraceutical. ACM Pharma operates under NF EN ISO/CEI 17025 (COFRAC accreditation No. 1-7464), holds ANSM pharmaceutical establishment authorization and GMP certificates for human and experimental medicines, ANSES/ANMV veterinary GMP authorization, and FDA establishment registration (FEI 3004177283).
The technical platform centers on conventional microbiological methods augmented by rapid/alternative systems, notably the BacT/ALERT 3D® automated microbial detection system, which enables a 48-hour cosmetic cleanliness release service, and the ENDONEXT™ endotoxin detection platform. Environmental monitoring follows the NF EN 17141 standard (PDCA methodology). R&D services extend the offering into probiotics/prebiotics/synbiotics, biofilm and microbial adhesion studies, and cell/microorganism interaction research, supported by French Crédit Impôt Recherche eligibility through 2027. ACM Pharma is part of Teranga Groupe, which also includes sister firms CEBIPHAR and UPS Consultants.
ACM Pharma earns revenue through professional-services fees on customized, quote-based engagement packages, typically structured as multi-year contracts. It reports serving 500+ client partners with a 2025 customer satisfaction rate above 92%. Go-to-market is sales-led and direct to enterprise customers, supported by a dedicated client web portal (webclient.acmpharma.com), active LinkedIn presence, conference participation (Anemcoli, A3P), and a scientific newsletter. No public revenue figure, ownership percentage, or investor identity is disclosed; ownership rests within Teranga Groupe.
ACD Pharma firmographics
Firmographics- Name
- ACD Pharma
- Legal name
- SARL ACM Pharma
- Website
- https://acmpharma.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- ACM Pharma is a French B2B microbiological testing laboratory (NF EN ISO/CEI 17025-accredited, GMP-compliant) serving pharmaceutical, cosmetic, biopharmaceutical, medical device, biocides, and nutraceutical manufacturers with contamination control, method validation, and disinfectant efficacy testing.
- Ownership category
- akta.pro rank
ACD Pharma industry classification
Industry- Product category
- Pharmaceutical Laboratory Testing Services
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)
- akta.pro secondary industries
- Environmental Monitoring & Cleanroom Testing (GMP) (HLAGADAL), Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
Keywords
Where ACD Pharma is headquartered
LocationHeadquarters
- HQ city
- Leknes
- HQ country
- Norway
- HQ region
- Europe
Offices2 records
Markets served
ACD Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
Revenue model
- Laboratory Testing Services: Microbiological and physico-chemical analysis services for pharmaceutical, biopharmaceutical, cosmetic, medical device, biocides, and nutraceutical industries. Services include product testing, method development and validation, environmental monitoring, cleaning validation, and disinfectant efficacy testing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Customized service packages based on client requirements |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
ACD Pharma product offering
Product offeringCore offering
ACM Pharma operates ISO/IEC 17025 accredited and cGMP-compliant laboratories delivering microbiological and physico-chemical testing services for contamination control across pharmaceutical, biopharmaceutical, cosmetic, medical device, biocide, and nutraceutical industries. Core offerings include microbial identification, sterility testing, endotoxin testing, challenge tests, cleaning validation, environmental monitoring, disinfectant efficacy validation, and R&D services in probiotics, biofilms, and cell-microorganism interactions. The company operates two laboratory sites in France (Bellegarde and Toulouse) and holds ANSM pharmaceutical establishment authorization, FDA registration, and COFRAC ISO 17025 accreditation.
Product overview
ACM Pharma (Fonderephar) operates as a laboratory services company offering contamination control and microbiological testing as a unified portfolio of services. The core offering consists of microbiological analyses (microbial identification, contamination testing, bioburden, sterility testing, MIC/MBC, challenge tests, endotoxins, water analysis) supplemented by rapid methods (BacT/ALERT 3D® for 48h results), physico-chemical analyses, cleaning validation, environmental monitoring, and disinfection effectiveness testing. R&D services cover probiotics, biofilms, and cellular interactions. Services are organized by industry vertical (pharmaceutical, biopharmaceutical, cosmetic, medical device, biocides, nutraceutical) and comply with Ph Eur, USP, NF EN ISO standards, BPF/GMP, and ISO 17025 accreditation.
Differentiator
Problem solved
Functional benefit
Products and services
- Microbiological Analyses Comprehensive microbiological testing services including microbial identification, microbial contamination testing, bioburden on medical devices, and sterility testing performed in NF EN ISO/CEI 17025 accredited laboratories.
- MIC/MBC – MIC/MFC Testing Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) testing services for pharmaceutical and cosmetic applications.
- Challenge Test Services Preservation efficacy testing and challenge tests to evaluate the effectiveness of antimicrobial preservatives in products.
- Bacterial Endotoxins Testing Testing services for bacterial endotoxins to ensure product safety in pharmaceutical and biopharmaceutical applications.
- Water Analysis Services Comprehensive water testing services for pharmaceutical manufacturing and controlled environments.
- Molecular Biology & Biotesting Molecular biology techniques and biotesting services for advanced microbiological analysis.
- Rapid Microbiological Methods Alternative rapid microbiological methods including automated detection systems like BacT/ALERT 3D for faster results (48h for cosmetic cleanliness testing).
- Physico-chemical Analyses Physical and chemical analysis services complementing microbiological testing.
- Cleaning Validation Validation services for cleaning procedures in pharmaceutical manufacturing environments.
- Environmental Monitoring Monitoring services for controlled environments and cleanrooms (ZAC) to ensure compliance with ISO 14698 and NF EN 17141 standards.
- Disinfection Technology Effectiveness Validation testing for disinfectants including virucidal, bactericidal, fungicidal, sporicidal, and mycobactericidal efficacy testing per NF EN 17387 and Annexe 1 requirements.
- Probiotics, Prebiotics & Synbiotics Research Research and development services focused on probiotics, prebiotics, and synbiotics including cellular interaction studies.
- Microbial Adhesion and Biofilms Research Specialized R&D services studying microbial adhesion and biofilm formation mechanisms.
- Cell/Microorganism Interactions Research Research on interactions between cells and microorganisms including virology studies.
- Pharmaceutical Industry Services Contamination control services tailored for pharmaceutical manufacturers including BPF/GMP compliance.
- Biopharmaceutical Industry Services Specialized testing services for biopharmaceutical production including biologics and biosimilars.
- Cosmetic Industry Services Microbiological quality control services for cosmetic manufacturers meeting ISO 22716 and CSAR standards.
- Medical Device Industry Services Bioburden testing and sterility testing services for medical device manufacturers.
- Biocides Industry Services Efficacy testing services for biocide products including disinfectants and antiseptics.
- Nutraceutical Industry Services Quality control testing services for nutraceutical and food supplement products.
- BacT/ALERT 3D Rapid Release Service Automated microbiological detection service using BacT/ALERT 3D system providing cosmetic cleanliness results in 48 hours for rapid product release.
Quantifiable outcome
- 92%+ customer satisfaction rate
- +2 more outcomes
Companies that use ACD Pharma
Customer profileNamed customers5 records
Segments6 records
Ideal customer profiles6 records
ACD Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
ACD Pharma partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- SEPPICminorCollaborative partnership for biofilm research presentation at Anemcoli 2025 event. SEPPIC and ACM Pharma expert Catherine Feuillolay collaborated on biofilm research in cosmetic microbiology.
- Teranga GroupecoreTeranga Groupe is the parent holding company that unites ACM Pharma with sister companies CEBIPHAR and UPS Consultants. The group provides comprehensive solutions for health industries through complementary offerings in product development, regulatory support, and quality control.
- CEBIPHARcoreSister company within Teranga Groupe providing personalized support for development and quality control of health products, complementing ACM Pharma's contamination control expertise.
- UPS ConsultantscoreSister company within Teranga Groupe offering training, consulting, audit, and technical assistance services for over 20 years, working synergistically with ACM Pharma for comprehensive client support.
Scale indicators2 records
Recent moves7 records
Expansion highlights2 records
ACD Pharma competitors and assessment
Company assessmentDirect peers
- Eurofins Scientific: Eurofins is the largest European network of testing laboratories, with strong pharmaceutical, cosmetic and microbiological testing franchises that directly overlap with ACM Pharma's sterility, endotoxin, bioburden and environmental monitoring service lines.
- Charles River Laboratories: Charles River is a leading biopharmaceutical and medical-device testing services provider with substantial microbiology, endotoxin and sterility testing capacity, closely mirroring ACM Pharma's GMP-compliant contamination-control offering for biopharma clients.
- Mérieux NutriSciences: Part of Institut Mérieux, Mérieux NutriSciences provides food, cosmetic and nutraceutical testing services with strong microbiological expertise. Its vertical focus on cosmetics and nutraceuticals mirrors ACM Pharma's industry mix and service categories.
- Nelson Labs: Nelson Labs is a specialist medical-device and pharmaceutical testing laboratory focused on sterilization, bioburden, endotoxin and packaging testing. Its medical-device sterility testing and cleanroom validation work closely resembles ACM Pharma's biopharma and medical-device contamination-control services.
- bioMérieux: bioMérieux is a microbiology-focused in vitro diagnostics and industrial testing company whose industrial microbiology division sells instruments (including BacT/ALERT platforms) and services to pharmaceutical and cosmetic labs. It both supplies technology used by ACM Pharma and competes in adjacent microbiological testing workflows.
Broad incumbents
- SGS: SGS is a global inspection, verification, testing and certification company with broad life-sciences testing capabilities. While not specialized solely in microbiology, its pharmaceutical-quality testing menus directly substitute for ACM Pharma's service portfolio across multiple verticals.
- Intertek: Intertek is a global quality-assurance provider with dedicated pharmaceutical and cosmetic testing services, including microbial and chemical testing for batch release. Overlap with ACM Pharma is strong on the quality-control testing side for regulated industries.
- ALS Limited: ALS is a global testing services network covering pharmaceutical, environmental and food testing. Its microbiology and life-sciences division competes with ACM Pharma for industrial contamination control and batch-release testing work in regulated industries.
- Bureau Veritas: Bureau Veritas is a global testing, inspection and certification group with commodity and consumer goods testing. Its health-industry testing offerings, including cosmetics and personal care product testing, overlap with selected parts of ACM Pharma's portfolio.
- Labcorp Drug Development (formerly Covance): Labcorp's drug-development division provides central-lab and specialty testing services for pharmaceutical and biopharma clients, including microbiology and biomarker work. While broader in clinical and central-lab offerings, it overlaps with ACM Pharma on regulated industry testing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
ACD Pharma social profiles
Digital presenceACD Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
ACD Pharma leadership team
Management profileNumber of profiles
Profiles1 record
ACD Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ACD Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ACD Pharma
What does ACD Pharma do?
ACM Pharma operates ISO/IEC 17025 accredited and cGMP-compliant laboratories delivering microbiological and physico-chemical testing services for contamination control across pharmaceutical, biopharmaceutical, cosmetic, medical device, biocide, and nutraceutical industries. Core offerings include microbial identification, sterility testing, endotoxin testing, challenge tests, cleaning validation, environmental monitoring, disinfectant efficacy validation, and R&D services in probiotics, biofilms, and cell-microorganism interactions. The company operates two laboratory sites in France (Bellegarde and Toulouse) and holds ANSM pharmaceutical establishment authorization, FDA registration, and COFRAC ISO 17025 accreditation.
Is ACD Pharma a public or private company?
ACD Pharma is a private company. It is classified as corporate owned and is currently operating.
When was ACD Pharma founded?
ACD Pharma was founded in 2011. It employs 51 to 100 people.
Where is ACD Pharma based?
ACD Pharma is headquartered in Leknes, Norway, in the Europe region.
How does ACD Pharma make money?
One revenue line is on record: laboratory Testing Services.
Who are ACD Pharma's main competitors?
Direct peers on record are Eurofins Scientific, Charles River Laboratories, Mérieux NutriSciences, Nelson Labs and bioMérieux. Broad incumbents are SGS, Intertek, ALS Limited, Bureau Veritas and Labcorp Drug Development (formerly Covance).
Does ACD Pharma have an API?
No public API is recorded for ACD Pharma.
What industry is ACD Pharma in?
ACD Pharma's product category is Pharmaceutical Laboratory Testing Services. Its primary akta.pro industry code is HLAGADAE, Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility), with a secondary code of HLAGADAL, Environmental Monitoring & Cleanroom Testing (GMP). Its NAICS code is 621511 and its SIC code is 8071.